发明名称 |
Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
摘要 |
The present invention relates to a method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from mammalian blood/use of a device comprising a carbohydrate immobilized on a solid substrate, said carbohydrate having a binding affinity for a pathogenic microbe, an inflammatory cell or an inflammatory protein, for extracorporeal removal of said pathogenic microbe, inflammatory cell or inflammatory protein from mammalian blood/use of a carbohydrate having a binding affinity for a pathogenic microbe, an inflammatory cell or an inflammatory protein, wherein said carbohydrate is immobilized on a solid substrate, in the preparation of a device for treatment of a condition caused or aggravated by said pathogenic microbe, inflammatory cell or inflammatory protein/and a method for treatment of a mammalian subject suffering from a condition caused or aggravated by a pathogenic microbe, an inflammatory cell or an inflammatory protein. |
申请公布号 |
US9173989(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US200612086126 |
申请日期 |
2006.12.13 |
申请人 |
EXTHERA MEDICAL CORPORATION |
发明人 |
Larm Olle;Bergström Tomas |
分类号 |
A61K35/14;A01N1/02;A61M1/36;A61K31/70 |
主分类号 |
A61K35/14 |
代理机构 |
Kilpatrick Townsend & Stockton LLP |
代理人 |
Kilpatrick Townsend & Stockton LLP |
主权项 |
1. A method for treating a subject in need thereof, by extracorporeal removal of Staphylococcus aureus, said method comprising:
a) contacting said subject's whole blood with heparin immobilized on a solid substrate, said heparin having a terminal residue, wherein heparin immobilization consists of a single covalent link of said terminal residue to said solid substrate by covalent end-point attachment, under conditions allowing binding of said Staphylococcus aureus in said subject's whole blood sample to the heparin; b) separating the whole blood from the solid substrate; c) recovering said whole blood containing a reduced amount of said Staphylococcus aureus; and d) reintroducing into said subject said whole blood containing a reduced amount of said Staphylococcus aureus. |
地址 |
Berkeley CA US |